PITTSBURGH, March 25, 2011 (GLOBE NEWSWIRE) -- HWI Global, Inc., the Pittsburgh-based clean room design builder recently merged with IVT Software, Inc. (OTCBB:IVTW), announces the Company has been awarded a contract at the new University of Pittsburgh Medical Center facility in Monroeville, PA. HWI will provide USP 797 consultation and interior fit and finish services, commonly known as a "clean room", for the sterile compounding pharmacy at UPMC EAST. HWI was specified for this project by BBH Design, one of the largest architectural firms in Research Triangle Park, NC, an industrial community in which HWI has established a presence.
Deric A. Haddad, CEO, HWI Global states, "We are always pleased to do work for UPMC, not only because of our common Pittsburgh heritage but because we share the same goals, to innovate and expand. It's gratifying that an architectural firm as highly-regarded as BBH Design chose us as the marquee standard of how to design and build a 797 sterile compounding pharmacy clean room."
HWI has entered into a subcontract for this 300,000 sq. ft, 156-bed hospital on a 15-acre site in Monroeville, PA. Builder/developer P. J. Dick, and Joint Venture Partner construction firm Barton-Malow, have joined forces to provide the lead in construction management services.
About HWI Global, Inc.
HWI Global is a leader in clean-room design engineering and construction, servicing clients in the Life Science, Health Science, Nanotechnology, Microelectronics and Aerospace industries. HWI Global and its network of subject matter experts (SME) -- from leading architects, engineers, facilities planners, and specialized installers -- effectively design and construct the most state-of-the-art clean environments in a "turnkey" fashion.
Safe Harbor Statements
This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approvals for anticipated actions. This press release shall not constitute an offer to issue or sell, or the solicitation of an offer to buy securities, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.
CONTACT: Investor Relations: Mark Kabbash, 646-408-2661 firstname.lastname@example.org or Media Relations: Jerry Jennings, 561-881-7318 email@example.com